Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Merrimack Pharmaceut (MACK)

1.35 -0.11 (-7.53%)

6/23/2017  4:00pm

Open:

1.50

Pre. Close:

1.46

High:

1.50

Low:

1.33

Volume:

4,364,691

Market Cap:

178.78M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.52 - 1.54

1.54 - 1.56

Low:

1.26 - 1.28

1.28 - 1.31

Close:

1.31 - 1.35

1.35 - 1.38

Technical analysis  (as of: 2017-06-23 4:36:23 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 3.14     One year: 4.26

Support:

Support1: 1.13    Support2: 0.94

Resistance:

Resistance1: 2.69    Resistance2: 3.65

Pivot:

1.37

Moving Averages:

MA(5): 1.32     MA(20): 1.74

MA(100): 2.92     MA(250): 4.23

MACD:

MACD(12,26): -0.46     Signal(12,26,9): -0.49

%K %D:

%K(14,3): 23.50     %D(3): 15.54

RSI:

RSI(14): 29.17

52-Week:

High: 6.79  Low: 1.13  Change(%): -77.9

Average Vol(K):

3-Month: 122986  10-Days 5050

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MACK has closed above bottom band by 46.1%. Bollinger Bands are 29.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 08 Jun 2017 10:56:26 GMT
Merrimack Announces Expansion of Senior Management Team with Appointment of ...

Wed, 31 May 2017 18:56:15 GMT
As Merrimack shares hit new low, CEO vows to stay the course

Fri, 26 May 2017 13:07:30 GMT
Merrimack Pharmaceuticals, Inc. (MACK) Ex-Dividend Date Scheduled for May 30, 2017

Wed, 31 May 2017 14:48:45 GMT
Why Merrimack Pharmaceuticals Stock Is Tanking Today

Fri, 23 Jun 2017 11:26:15 GMT
Target Price for Merrimack Pharmaceuticals, Inc. (MACK) now above Year Low for ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

132.43

Shares Float (M)

116.48

% Held by Insiders

10.51

% Held by Institutions

69.70

Shares Short (K)

24940

Shares Short Prior Month (K)

24900

Stock Financials

EPS

-1.110

EPS Est. Current Year

-0.570

EPS Est. Next Year

-0.730

EPS Est. Next Quarter

-0.080

Forward EPS

-0.731

Book Value (p.s.)

-2.090

PEG Ratio

-0.51

Profit Margin

-99.08

Operating Margin

-65.34

Return on Assets (ttm)

-45.0

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

1.037

Sales Per Share

EBITDA (p.s.)

-0.665

Qtrly Earnings Growth

Operating Cash Flow (M)

-126.87

Levered Free Cash Flow (M)

-58.40

FoxReading.com

Valuation

P/E

-1.22

P/E Growth Ratio

-0.08

P/BV

-0.65

P/S

159625456.00

P/CF

-1.41

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2017-05-26

Ex-Dividend Date

2017-05-30

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.